AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile

Recruitingn/aAges 50 Years - 70 YearsAllInstitut Investigacio Sanitaria Pere Virgili
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Colorectal cancer is the most frequent tumor in our environment if both sexes are considered together. Every year almost 800 cases are diagnosed in the districts of Tarragona. A little more than half of colorectal cancers are cured with surgery, with or without the addition of complementary treatments with chemotherapy and/or radiation therapy. Those who are not cured is because at the time of diagnosis the disease has already spread or they spread after having been treated surgically with curative intent. The purpose of the EarlyCRC project is to determine whether metabolites (substances of low molecular weight) can be found in the urine and stool of patients with colorectal cancer or polyps that can be easily and cheaply differentiated (urine or stool analysis) between the patients affected by colorectal cancer or polyps, from healthy individuals. For the identification of these possi

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with a positive FOBT test result from the Colorectal Cancer Early Detection Program and referred for a colonoscopy. Exclusion Criteria: * Patients diagnosed with another primary neoplasm in the last 5 years, with the exception of carcinoma in situ of the cervix or non-melanoma skin cancer. * Patients with severe kidney disease stage IV (creatinine clearance \< 30 ml/min). * Patients with severe active liver disease (hepatitis, cirrhosis). * Refusal to sign informed consent.
๐Ÿ’Š

What it tests

  • Colonoscopy
  • Urine and FOBT collection
๐Ÿ“

Where

2 sites
Hospital Universitari Sant Joan de Reus
Reus, Spain
Hospital Universitari Joan XXIII
Tarragona, Spain
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy